
Sign up to save your podcasts
Or


Alan Doherty, Clinical Director at the Birmingham Prostate Clinic, and recently voted one of the UK’s top ten prostate cancer specialists in a national poll of consultant urologists published in the Daily Mail, joins OnFocus to discuss the recently published study led by Imperial College comparing outcomes of men undergoing focal therapy and radical prostatectomy. Alan has been an innovator, advocate and dedicated practitioner of precision treatments for prostate cancer, and thinks the study’s real impact will be felt amongst men considering Active Surveillance.
By The Focal Therapy ClinicAlan Doherty, Clinical Director at the Birmingham Prostate Clinic, and recently voted one of the UK’s top ten prostate cancer specialists in a national poll of consultant urologists published in the Daily Mail, joins OnFocus to discuss the recently published study led by Imperial College comparing outcomes of men undergoing focal therapy and radical prostatectomy. Alan has been an innovator, advocate and dedicated practitioner of precision treatments for prostate cancer, and thinks the study’s real impact will be felt amongst men considering Active Surveillance.